首页> 美国卫生研究院文献>The Journal of Experimental Medicine >Passive transfer of autoimmune disease with isologous IgG1 and IgG2 antibodies to the tubular basement membrane in strain XIII guinea pigs: loss of self-tolerance induced by autoantibodies
【2h】

Passive transfer of autoimmune disease with isologous IgG1 and IgG2 antibodies to the tubular basement membrane in strain XIII guinea pigs: loss of self-tolerance induced by autoantibodies

机译:带有同种IgG1和IgG2抗体的自身免疫性疾病向XIII豚鼠的肾小管基底膜的被动转移:自身抗体诱导的自我耐受性丧失

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Initiation of an autoimmune tubulointerstitial disease was achieved in strain XIII guinea pigs by passive transfer of functionally pure IgG1 or IgG2 fractions of isologous anti-tubular basement membrane (TBM) serum. IgG2 appeared to be somewhat more effective than IgG1. The immunopathologic features in the IgG1 and IgG2 recipients were similar at the time of sacrifice, 14 days after transfer. The recipients that developed disease had higher than expected anti-TBM titers at 14 days. Furthermore, anti-TBM antibodies were of both IgG isotypes. In contrast, simultaneously administered IgG1 or IgG2 anti-BGG antibodies declined in titer in the recipients and were never found in the isotype fraction that had not been transferred. These findings indicate that the recipients of anti-TBM antibodies of either IgG1 or IgG2 isotype were stimulated to produce anti-TBM autoantibodies, which participated in the pathogenesis of the renal disease. The model demonstrates that autoantibodies may provide a mechanism (autoimmune amplification) for the intensification and perpetuation of antibody-mediated autoimmune diseases.
机译:通过被动转移异源抗肾小管基底膜(TBM)血清中功能纯的IgG1或IgG2组分,在XIII豚鼠中实现了自身免疫性肾小管间质疾病的发作。 IgG2似乎比IgG1更有效。 IgG1和IgG2受体的免疫病理特征在处死时,转移后14天相似。患病的受者在14天时的抗TBM效价高于预期。此外,抗TBM抗体是两种IgG同种型。相反,同时给予的IgG1或IgG2抗BGG抗体的滴度在接受者中下降,而从未被转运的同种型中从未发现。这些发现表明,刺激了IgG1或IgG2同种型的抗TBM抗体的受体产生抗TBM自身抗体,其参与了肾脏疾病的发病机理。该模型表明,自身抗体可能为抗体介导的自身免疫性疾病的强化和永续提供机制(自身免疫性扩增)。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号